K183640 is an FDA 510(k) clearance for the Cellvizio 100 Series Confocal laser Imaging systems and their Confocal Miniprobes. This device is classified as a Confocal Optical Imaging (Class II - Special Controls, product code OWN).
Submitted by Mauna Kea Technologies (Paris, FR). The FDA issued a Cleared decision on February 22, 2019, 58 days after receiving the submission on December 26, 2018.
This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 876.1500. Collection Of Light Signals For Visualization Of Cellular Microstructures..